Fig. 3From: Change in neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinomaNeutrophil-to-lymphocyte ratio (NLR) at week 6 (a) and percent (%) change of NLR at week 6 (b) according to response to therapy (complete/partial response, CR/PR; stable disease, SD; progressive disease, PD)Back to article page